Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Strippoli

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|April 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer CellsFrancesco Fiorentino, Giulio Bontempi, Federica Michetti, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Scientific Reports|February 7, 2018
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancerTeijo Pellinen, Sami Blom, Sara Sánchez, et al.
Clinical Epigenetics|September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Communications|December 22, 2019
An Abl-FBP17 mechanosensing system couples local plasma membrane curvature and stress fiber remodeling during mechanoadaptationAsier Echarri, Dácil M Pavón, Sara Sánchez, et al.
The Lancet. Rheumatology|January 30, 2024
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort studyChristoph Kessel, Ndate Fall, Alexei Grom, et al.
Cell Death & Disease|August 20, 2020
Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosisRaffaele Strippoli, Pilar Sandoval, Roberto Moreno-Vicente, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|April 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer CellsFrancesco Fiorentino, Giulio Bontempi, Federica Michetti, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Scientific Reports|February 7, 2018
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancerTeijo Pellinen, Sami Blom, Sara Sánchez, et al.
Clinical Epigenetics|September 28, 2022
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Communications|December 22, 2019
An Abl-FBP17 mechanosensing system couples local plasma membrane curvature and stress fiber remodeling during mechanoadaptationAsier Echarri, Dácil M Pavón, Sara Sánchez, et al.
The Lancet. Rheumatology|January 30, 2024
Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort studyChristoph Kessel, Ndate Fall, Alexei Grom, et al.
Cell Death & Disease|August 20, 2020
Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosisRaffaele Strippoli, Pilar Sandoval, Roberto Moreno-Vicente, et al.
Pageof 9